Results 1 to 10 of about 17,451 (214)

Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Δ30 with those of DEN1 [PDF]

, 2007
Background Antigenic chimeric viruses have previously been generated in which the structural genes of recombinant dengue virus type 4 (rDEN4) have been replaced with those derived from DEN2 or DEN3.
Blaney Joseph E, Sathe Neeraj S, Hanson Christopher T, Firestone Cai, Murphy Brian R, Whitehead Stephen S   +5 more
core   +2 more sources

Bibliography on inactivation of viruses and rickettsiae by heat [PDF]

Inactivation of viruses and rickettsiae by heat ...
Homann, L. M., Watson, M. S.
core   +1 more source

Global research priorities for infections that affect the nervous system [PDF]

, 2015
Infections that cause significant nervous system morbidity globally include viral (for example, HIV, rabies, Japanese encephalitis virus, herpes simplex virus, varicella zoster virus, cytomegalovirus, dengue virus and chikungunya virus), bacterial (for ...
Bangirana, Paul, Carabin, Hélène, John, Chandy C., Montano, Silvia M., Peterson, Phillip K., Zunt, Joseph R.   +5 more
core   +1 more source

Epidemiological trends and characteristics of Japanese encephalitis changed based on the vaccination program between 1960 and 2013 in Guangxi Zhuang Autonomous Region, southern China

International Journal of Infectious Diseases, 2016
Japanese encephalitis (JE) is one of the most severe kinds of viral encephalitis and is prevalent in Asia and the Western Pacific. In China, JE was first reported in the 1940s and became the main cause of viral encephalitis, including in the Guangxi ...
Yan Yang, Nengxiu Liang, Yi Tan, Zhichun Xie   +3 more
doaj   +1 more source

Vaccine [PDF]

BackgroundIn March 2009, the U.S. Food and Drug Administration licensed an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC [Ixiaro]) for use in adults. The vaccine was licensed based on clinical trial safety data in 3558 JE-VC

core  

Suppression of Type I Interferon Signaling by Flavivirus NS5. [PDF]

, 2018
Type I interferon (IFN-I) is the first line of mammalian host defense against viral infection. To counteract this, the flaviviruses, like other viruses, have encoded a variety of antagonists, and use a multi-layered molecular defense strategy to ...
Hai, Rong, Song, Jikui, Thurmond, Stephanie, Wang, Boxiao   +3 more
core  

Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020. [PDF]

, 2017
OBJECTIVE: To estimate the economic impact likely to be achieved by efforts to vaccinate against 10 vaccine-preventable diseases between 2001 and 2020 in 73 low- and middle-income countries largely supported by Gavi, the Vaccine Alliance.
Clark, Andrew, Clark, Samantha, Ferrari, Matthew, Franklin, Heather, Friberg, Ingrid K, Garske, Tini, Goldie, Sue J, Grewal, Simrun, Hansen, Peter M, Johnson, Hope L, Li, Michelle, Mirelman, Andrew, Ozawa, Sachiko, Portnoy, Allison, Sinha, Anushua, Stack, Meghan L, Suraratdecha, Chutima, Sweet, Steven, Tam, Yvonne, Walker, Damian, Walker, Neff   +20 more
core   +4 more sources

Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.

PLoS Neglected Tropical Diseases, 2019
Genotype III (GIII) Japanese encephalitis virus (JEV) predominance has gradually been replaced by genotype I (GI) over the last 20 years in many Asian countries.
Jianchao Wei, Xin Wang, Junjie Zhang, Shuang Guo, Linlin Pang, Kun Shi, Ke Liu, Donghua Shao, Yafeng Qiu, Lihong Liu, Frederik Widén, Beibei Li, Zhiyong Ma   +12 more
doaj   +1 more source

Mission to Indonesia to participate to the 1st Indonesia- France Seminar in Medicine & Public Health and investigate potential collaborations on animal health : 2nd - 9th of November 2012 [PDF]

, 2012
Emerging and zoonotic infectious diseases are a major issue in Indonesia. The objective of this mission, funded by the Institut Français d'Indonésie (IFI), was to identify potential subjects of collaboration between CIRAD, Pasteur Institute, and ...
Bourhy, Hervé, Gaidet, Nicolas, Molia, Sophie   +2 more
core  

Investigating Nonspecific Effects of the Live-Attenuated Japanese Encephalitis Vaccine on Lower Respiratory Tract Infections in Children Aged 25-35 Months: Retrospective Cohort Study

JMIR Public Health and Surveillance
BackgroundLive attenuated vaccines may be used to prevent nontargeted diseases such as lower respiratory tract infections (LRTIs) due to their nonspecific effects (NSEs).
Siyi Zhan, Hongbo Lin, Yingying Yang, Tao Chen, Sheng Mao, Chuanxi Fu   +5 more
doaj   +1 more source